Eliem Therapeutics Inc (ELYM)
10.16
+1.76
(+21.04%)
USD |
NASDAQ |
May 03, 16:00
10.14
-0.02
(-0.15%)
After-Hours: 20:00
Eliem Therapeutics 1 Year Total Returns (Daily): 196.9% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | 196.9% |
May 02, 2024 | 139.7% |
May 01, 2024 | 138.1% |
April 30, 2024 | 125.8% |
April 29, 2024 | 59.87% |
April 26, 2024 | 32.67% |
April 25, 2024 | 5.94% |
April 24, 2024 | 29.33% |
April 23, 2024 | 18.30% |
April 22, 2024 | 22.08% |
April 19, 2024 | 19.94% |
April 18, 2024 | 34.84% |
April 17, 2024 | 37.15% |
April 16, 2024 | 44.76% |
April 15, 2024 | 50.79% |
April 12, 2024 | 44.63% |
April 11, 2024 | 43.12% |
April 10, 2024 | -17.34% |
April 09, 2024 | -10.33% |
April 08, 2024 | -10.33% |
April 05, 2024 | -20.00% |
April 04, 2024 | -10.00% |
April 03, 2024 | -4.48% |
April 02, 2024 | -3.10% |
April 01, 2024 | -3.45% |
Date | Value |
---|---|
March 28, 2024 | -16.46% |
March 27, 2024 | -14.55% |
March 26, 2024 | -15.58% |
March 25, 2024 | -13.71% |
March 22, 2024 | -15.36% |
March 21, 2024 | -22.00% |
March 20, 2024 | -13.08% |
March 19, 2024 | -15.24% |
March 18, 2024 | -14.33% |
March 15, 2024 | -11.18% |
March 14, 2024 | -13.50% |
March 13, 2024 | 2.55% |
March 12, 2024 | -15.61% |
March 11, 2024 | -6.83% |
March 08, 2024 | -25.00% |
March 07, 2024 | -19.52% |
March 06, 2024 | -20.29% |
March 05, 2024 | -17.06% |
March 04, 2024 | -19.86% |
March 01, 2024 | -31.55% |
February 29, 2024 | -23.31% |
February 28, 2024 | -22.76% |
February 27, 2024 | -24.45% |
February 26, 2024 | -25.00% |
February 23, 2024 | -26.67% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-89.62%
Minimum
Sep 07 2022
196.9%
Maximum
May 03 2024
-35.57%
Average
-25.00%
Median
Jan 22 2024
1 Year Total Returns (Daily) Benchmarks
Alpine Immune Sciences Inc | 824.2% |
Candel Therapeutics Inc | 467.3% |
Cyclacel Pharmaceuticals Inc | -75.76% |
Lipocine Inc | 10.12% |
GlycoMimetics Inc | 34.56% |